We continue to conduct clinical studies and work with our key opinion leaders to pursue additional applications for which our cell-specific mechanism of action is enabling. We have already started our evaluation for the treatment of warts, acne and basal cell carcinoma. Our application development pipeline continues to reveal additional targets that add to the utilization potential of our future growing installed base.

Clinical Roadmap